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Abstract To elucidate the mechanism of the circadian rhythm,
genes differentially expressed during subjective day and night in
the rat suprachiasmatic nucleus (SCN), a circadian oscillator in
mammals, were surveyed by a differential display method. We
isolated a novel gene, scop (SCN circadian oscillatory protein),
that was expressed in a circadian manner in the SCN. SCOP
protein is predominantly expressed in the brain and has domains
including a pleckstrin homology domain, leucine-rich repeats, a
protein phosphatase 2C-like domain and a glutamine-rich region.
The structural feature of SCOP protein suggests its role in the
intracellular signaling in the SCN.
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1. Introduction
Almost all living organisms show circadian rhythms in their
behaviors and physiological phenomena [1,2]. These circadian
rhythms are driven by an endogenous oscillator with a period
of about 24 h, and are synchronized to exactly 24 h by envi-
ronmental time cues on the earth such as the light-dark cycle.
In mammals, a circadian oscillator is known to be located in
the hypothalamic suprachiasmatic nucleus (SCN) [1,2]. It has
been shown that the circadian rhythm in Drosophila requires
the interaction of Period (Per) and Timeless (Tim) proteins [3^
5], their heterodimer’s nuclear translocation [6,7] and the in-
hibitory regulation of per and tim transcriptions through an
autoregulatory feedback loop mechanism mediated by other
clock-related proteins, Jrk (Drosophila homolog of Clock) and
Cycle (Drosophila homolog of BMAL-1) [8]. Progress has
been made in cloning some mammalian homologs for Droso-
phila clock components to elucidate molecular components of
mammalian clocks [9^16]. Therefore, a framework of the
mechanism for the generation of the circadian oscillation
seems to be established. However, the precise mechanism
has not been fully clari¢ed yet.
In order to ¢nd genes that might be involved in the mech-
anism of the circadian rhythm in mammals, we tried to iden-
tify the genes whose mRNA expressions were di¡erent during
subjective day and night in the rat SCN. To this end, we
employed a mRNA di¡erential display method, which is
based on reverse transcription (RT) and arbitrarily primed
polymerase chain reaction (PCR), and identi¢ed a molecule
(we termed this protein SCOP for SCN circadian oscillatory
protein) that oscillates in the SCN under a constant dim light
condition. The characterization of this molecule is described.
2. Materials and methods
2.1. Animals
Male Wistar strain rats, weighing 250^350 g, were ¢rst housed in-
dividually in plastic cages in a room maintained at 24 þ 1‡C and
illuminated for 12 h (7.00^19.00 h) by £uorescent light (about 80
lux). Then, they were transferred to a room constantly illuminated
with a dim (about 0.2 lux) red light (DD) throughout the whole
day. Food (type MF; Oriental Yeast Co.) and water were freely
available. These rats were adapted to this condition for at least
7 days before the experiments.
2.2. Collection of the tissue of the SCN
For SCN samplings under the DD condition, the subjective circa-
dian time of each animal was determined by monitoring its locomotor
activity pattern. Animals were killed by decapitation at various circa-
dian times of the day, and their brains were quickly removed and
frozen in dry ice. Coronal brain sections with a thickness of 700 Wm
including the SCN were made using a cryostat, and bilateral SCNs
were punched out from the brain section using a 20-gauge needle.
Tissues outside the SCN within the hypothalamus which located dor-
solaterally to the SCN were similarly obtained.
2.3. mRNA di¡erential display method
Total RNA was isolated from the SCN tissues of ¢ve rats sampled
at circadian times (CT) 6 (the middle of the subjective light period)
and CT 18 (the middle of the subjective dark period) using the
RNeasy total RNA kit (Qiagen), and reverse-transcribed with an oligo
dT primer according to the protocol for SuperScript II (Gibco BRL).
In brief, denatured total RNA was incubated in a reaction mixture
(20 Wl) consisting of 50 mM Tris-HCl (pH 8.3), 71 mM KCl, 3 mM
MgCl2, 10 mM dithiothreitol, 0.5 mM dNTP and SuperScript II
(200 units) at 42‡C for 50 min, and the reaction was terminated by
heating at 70‡C for 15 min. To remove RNA complementary to the
cDNA, the reaction mixture was incubated with 2 units of RNase H
(Gibco BRL) at 37‡C for 20 min. One milliliter of the ¢rst strand
cDNA mixture (10-fold diluted) was used for arbitrarily primed PCR
(AP-PCR). AP-PCR was performed in a supplied Ex-Taq bu¡er (Ta-
kara) containing 0.5 mM of arbitrary primers, 0.2 mM of cold dNTP,
0.18 mCi/66 nmol/l of [K-32P]dCTP, and 2.5 U/ml Taq DNA polymer-
ase (Ex-Taq, Takara). PCR conditions were 95‡C for 5 min, 75‡C for
several minutes for hot start, 45‡C for 2 min and 72‡C for 2 min for
1 cycle, and then 95‡C for 1 min, 45‡C for 1 min, 72‡C for 1 min for
40 cycles. A ¢nal elongation cycle was performed at 72‡C for 5 min. A
6 ml aliquot of each PCR sample was mixed with 4 ml denaturing
loading bu¡er and heated at 78‡C for 3 min, and then resolved on a
6% denaturing polyacrylamide gel for DNA sequence. PCR products
were detected by autoradiography.
2.4. Subcloning of PCR products
Bands selected from the autoradiograms were excised from the
dried gel and the DNA was eluted by soaking in 50 ml TE bu¡er
(10 mM Tris-HCl, pH 7.6, 1 mM EDTA) at 4‡C for 2 days. One
milliliter of eluted cDNA solution was subjected to the secondary
PCR using the same primer set and PCR conditions except that
[K-32P]dCTP was omitted. The PCR products were treated with re-
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striction enzyme (BamHI, Takara), and subcloned into pBluescript II
SK3 vector.
2.5. Screening of cDNA library and sequencing
The cDNA fragment of SCOP was radiolabeled with multiprime
labeling kit (Amersham), and used as a probe to screen the rat hypo-
thalamic cDNA library (Takara) and the human fetal brain cDNA
library (Clontech) using standard laboratory protocols of molecular
cloning. DNA sequencing was carried out using the DNA Sequencing
kit (Big Dye Terminator Cycle Sequencing Ready Reaction, PE Ap-
plied Biosystems) and ABI 310 genetic analyzer (Perkin Elmer).
2.6. Competitive RT-PCR analysis
Total RNA was isolated from the SCN of each ¢ve rats killed at
CT 0, 6, 12 and 18 using RNeasy total RNA kit (Qiagen). Reverse
transcription was performed as described for AP-PCR. A competitor
for the scop gene was made by deleting 680 bp from the fragment (nt
1281^2293). A control competitor for glyceraldehyde 3-phosphate de-
hydrogenase (G3PDH) was constructed by the PCR-based overlap
extension method reported previously [17,18]. The competitor for
G3PDH was 145 bp shorter than the original insert. The nucleotide
sequences of the primers for the scop gene and its competitor were
(forward) 5P-TCCGAGGAACTAGAAGCTGA-3P and (reverse) 5P-
GCAAGACACATTCAGCTCTG-3P, and for G3PDH and its com-
petitor they were (forward) 5P-ACCACAGTCCATGCCATCAC-3P
and (reverse) 5P-TCCACCACCCTGTTGCTGTA-3P. PCR was car-
ried out in a supplied Ex-Taq bu¡er (Takara) containing 0.25 mM
primers, 0.2 mM cold dNTP, 2.5 U/ml Taq DNA polymerase (Ex
Taq, Takara), 0.68U1035 nM competitors. PCR was hot-started
under the conditions: 95‡C for 30 s, 75‡C for several minutes for
hot start, 60‡C for 30 s and 68‡C for 1 min for 1 cycle, and then
95‡C for 10 s, 60‡C for 10 s, 68‡C for 1 min for 29 cycles. A ¢nal
elongation cycle was performed at 68‡C for 5 min. For quantitative
analysis, aliquots of each PCR reaction were electrophoresed on 6%
polyacrylamide gels and then stained with ethidium bromide.
2.7. Expression of fusion proteins and antibody production
Anti-SCOP antiserum was raised against glutathione S-transferase
(GST)-SCOP fusion proteins containing the amino acids 735^1027
(GST-EC), 1029^1241 (GST-CB) and 1490^1696 (GST-C) of SCOP
(Fig. 2). For puri¢cation of anti-EC and anti-CB antibodies, maltose
binding protein (MBP)-SCOP fusion proteins containing the same
parts of antigen were prepared. The GST and MBP fusion proteins
were produced in Escherichia coli using pGEX (Pharmacia) and
pMAL (NEB) vectors, respectively. The GST fusion proteins mixed
with Freund’s complete adjuvant were injected to rabbits. The result-
ing antisera against GST-EC and -CB proteins (KEC and KCB) were
subjected to a⁄nity puri¢cation using the MBP fusion proteins
coupled to A⁄gel-10 (Bio-Rad). The antibody against GST-C protein
(KC) was puri¢ed using the GST fusion protein coupled to A⁄gel-10.
2.8. Preparation of protein samples and immunoblot analysis
Tissues except the SCN were homogenized in 8 volumes of TNE
bu¡er containing 20 mM Tris-HCl (pH 7.4), 1 mM EDTA, 0.15 M
NaCl, 1% Nonidet P-40, 5% glycerol, 5 mM L-mercaptoethanol,
10 mg/ml aprotinin, 10 mg/ml leupeptin and 1 mM PMSF. The
homogenates were centrifuged at 15 000Ug for 20 min at 4‡C. For
subcellular fractionation, the brain tissue was homogenized in ice-cold
10 volumes of 10 mM Tris-HCl (pH 7.4) containing 0.32 M sucrose,
and the homogenate was centrifuged at 1000Ug for 15 min (the ¢rst
centrifugation). The precipitate (ppt) was resuspended in the same
solution and centrifuged under the same conditions as above. The
ppt was designated the P1 fraction (nuclear fraction). The supernatant
(sup) was then combined with the sup from the ¢rst centrifugation
and centrifuged at 10 000Ug for 20 min. The ppt obtained was des-
ignated the P2 fraction (mitochondrial fraction). This sup was further
centrifuged at 100 000Ug for 60 min to separate the ppt, the P3
fraction (microsomal fraction), and the sup, the S fraction (cytosolic
fraction). All fractions were adjusted to the same volume with the
homogenization bu¡er. These protein samples were separated by 6%
SDS-PAGE gels and transferred electrophoretically to a nitrocellulose
membrane. After probing with anti-SCOP antibodies (1:400), immu-
noreactivities were visualized with alkaline phosphatase-conjugated
anti-rabbit IgG (1:3000) using NBT and BCIP as substrates.
The SCNs and the regions outside the SCN in the hypothalamus
punched out from ¢ve rats were directly homogenized in 100 Wl of
SDS sample bu¡er. To determine the protein concentration, these
samples were separated by SDS-PAGE and stained with Coomassie
brilliant blue. Immunoblot analysis was performed under the same
conditions as above except that the visualization was performed by
the chemiluminescence detection system (NEN).
3. Results
3.1. Isolation of di¡erentially expressed mRNAs in the SCN
In order to screen genes that are di¡erentially expressed in
the SCN between subjective circadian day and night, total
RNAs were prepared from the SCN tissue punched out
from brains of rats which were killed at CT 6 and CT 18.
The autoradiograms of the RNA ¢ngerprints showed that
most of the ampli¢ed fragments had similar radioactivities
at the two circadian times, when primer sets A^D were used
(Fig. 1). When primer E was used, however, there was a
dramatic change in the radioactivity of the ¢ngerprints be-
tween CT 6 and CT 18. Fourteen di¡erent bands were picked
up and reampli¢ed by PCR with the same primer. These
products were then subcloned, sequenced and reexamined
their expressions by RT-PCR using speci¢c primers for each
Fig. 1. Di¡erential display of mRNA in the rat SCN. Total RNAs
were prepared from the rat SCN at CT 6 and CT 18, and subjected
to di¡erential display using ¢ve sets of primers (A^E). Autoradio-
grams of the RNA ¢ngerprints are shown. Lanes 1, 3, 5, 7 and 9
indicate cDNAs sampled at CT 6, lanes 2, 4, 6, 8 and 10 at CT 18.
The arrow indicates the position of SCOP cDNA.
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clone. Consequently, only one clone (termed SCOP) was con-
¢rmed to be expressed di¡erentially (CT 66CT 18) in the
SCN.
Thus we focused on SCOP. We cloned a full-length cDNA
for the rat SCOP from the hypothalamic cDNA library and a
partial cDNA, lacking about 90 amino acids in its amino-
terminus, for a human counterpart from the fetal brain
cDNA library. The nucleotide sequence of the rat SCOP
cDNA suggested that the clone encodes a novel protein con-
sisting of 1696 amino acids (Fig. 2). The open reading frame
was con¢rmed by in vitro translation and immunoblot anal-
yses as described below. A similarity search for the deduced
amino acid sequence revealed that SCOP is a novel protein
that has multiple functional domains including a pleckstrin
homology (PH) domain, leucine-rich repeats (LRRs), a leu-
cine zipper (LZip), a protein phosphatase 2C (PP2C)-like do-
main and a glutamine-rich (Q-rich) region (Fig. 3A. The
LRRs of rat SCOP contain 18 repeats of consensus motif
and show the highest identity (28%) to the LRRs of the
Ras-binding protein SUR-8 (Fig. 3B). The PP2C-like domain
of SCOP is similar to not only PP2C catalytic domains of
yeast (28% identity) and Paramecium (26%), but also PP2C-
like domains of adenylate cyclases of yeast (26%) and smut
fungus (30%) (Fig. 3C). The amino acid sequences in these
Fig. 2. Alignment of amino acid sequences of rat and human SCOP. The PH domain (black line), the LRRs (dotted line), the leucine zipper
(gray line), the PP2C-like domain (double solid lines) and the Q-rich domain (meshed line) are underlined. Amino acid identity and similarity
between rat SCOP (rSCOP) and human SCOP (hSCOP) are indicated by asterisks and dots below the hSCOP sequence, respectively. The nu-
cleotide sequence data reported in this paper will appear in the DDBJ/EMBL/GenBank nucleotide sequence databases with the accession num-
ber AB023624.
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domains were highly conserved across rat and human, impli-
cating their crucial roles throughout evolution (Fig. 2).
3.2. Circadian changes in expressions of SCOP mRNA
The expression of SCOP mRNA in the SCN and a portion
of the hypothalamus outside the SCN under the DD condi-
tion was semi-quanti¢ed by competitive RT-PCR (Fig. 4). To
normalize the amount of mRNA in each sample, we used the
detection levels of G3PDH. The expression of SCOP mRNA
in the SCN was detected at the highest level at CT 24, grad-
ually decreased through CT 6, and reached the lowest level at
CT 12 under the DD condition. In the part of the hypothal-
amus outside the SCN, however, there was no change in the
expression of SCOP mRNA.
3.3. Expression of SCOP protein
In order to examine the expression of SCOP protein, we
raised three kinds of anti-SCOP antibodies that recognize
amino acid sequences 735^1027 (KEC), 1029^1241 (KCB)
and 1490^1696 (KC) of SCOP (Fig. 3A). Immunoblot analysis
demonstrated that in vitro translated product of the SCOP
cDNA was detected by these three antibodies, and that the
molecular size of the product (183 kDa) was the same as that
of the endogenous protein seen in the brain lysate (data not
shown), con¢rming that the antibodies indeed recognize the
SCOP protein.
The changes in the SCOP protein in the SCN were exam-
ined by immunoblot analysis using an anti-SCOP antibody
(KEC) (Fig. 5). The immunoreactivity at the position corre-
sponding to 183 kDa SCOP protein was readily detected in
the SCN, and the level of the immunoreactive protein in the
SCN increased during subjective night from CT 12 to CT 21
under the DD condition. In the hypothalamic part outside the
SCN, the level of the immunoreactivity for SCOP protein was
unchanged, consistent with the pattern of its mRNA expres-
sion.
The tissue distribution of SCOP protein was examined by
immunoblot analysis using KEC. Immunoreactivity corre-
sponding to 183 kDa SCOP protein was detected only in
Fig. 3. The domain structures of SCOP. A: Positions of PH, LRR, LZip, PP2C-like and Q-rich domains in the rat SCOP protein are shown.
The portions of SCOP protein to which antibodies were raised are indicated with upper bars (KEC, KCB and KC). B: Alignment of SCOP
LRRs and the consensus of rat SCOP, human SUR-8 and yeast adenylate cyclase (yeast AC) is shown. Residues conserved in the majority of
LRRs are shaded in black. Allowable substitutions for leucines within the LRRs are boxed. C: Comparison of the amino acid sequence of the
PP2C-like domain of SCOP with the sequences of PP2C1 of Schizosaccharomyces pombe (yeast PP2C1), adenylate cyclase of Saccharomyces
cerevisiae (yeast AC), adenylate cyclase of smut fungus (fungus AC), and PP2C of Paramecium tetraurelia (paramecium PP2C). Conserved ami-
no acids are shaded in black.
Fig. 4. Competitive RT-PCR using speci¢c primers for SCOP and
G3PDH. Samplings of the brain tissues were taken at CT 0, 6, 12
and 18 under constant dark (DD) condition, and total RNA was
prepared for the RT-PCR. Ethidium bromide stainings of the PCR
products are shown. vSCOP, a product of SCOP competitor;
vG3PDH, G3PDH competitor. The expressions of G3PDH mRNA
did not show daily changes in either the SCN or the part of the hy-
pothalamus outside the SCN.
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tissues of the central nervous system, cerebrum and cerebel-
lum (Fig. 6A). In the testis, a marked immunoreactivity mi-
grating slightly faster than the 183 kDa SCOP was detected by
KEC. The distribution of SCOP protein in the nervous system
was further analyzed by immunoblotting. As shown in Fig.
6B, immunoreactivity for SCOP protein was detected in var-
ious brain areas, but was relatively enriched in the hippocam-
pus and the cerebellum. The intracellular localization of
SCOP protein was examined by subcellular fractionation, fol-
lowed by immunoblot analysis (Fig. 6C). Comparable immu-
noreactivities for SCOP protein were detected in the nuclear
(P1), mitochondrial (P2) and cytosolic (S) fractions, poten-
tially representing heterogeneous localization of SCOP in
the cells. Immunoblot analysis for primary cultured rat brain
neurons and astrocytes demonstrated that the SCOP immu-
noreactivity was highly concentrated in neurons (data not
shown), suggesting speci¢c functions in neurons.
4. Discussion
Current understanding of the mechanism of the circadian
rhythm in mammals has progressed due to discoveries of
mammalian homologs for Per and Tim and other related
molecules [9^16]. Although mechanisms underlying circadian
rhythms are believed to be conserved between £ies and mam-
mals, there is no direct evidence that the Drosophila system
can indeed be applied to mammals. Moreover, the output
mechanism downstream of the endogenous oscillation loop
in the SCN is thoroughly unknown. In this study, we isolated
a new gene, scop, that is expressed in a circadian manner in
the SCN. By competitive RT-PCR and immunoblot analyses,
it was found that the SCOP mRNA and protein in the SCN
were high at dawn (CT 0 or CT 24) and low at dusk (CT 12)
under the DD condition (Figs. 4 and 5). In contrast, there was
no signi¢cant change in the level of SCOP mRNA outside the
SCN under the DD condition. These ¢ndings suggest that the
expression of SCOP protein is related to the generation or
transmission of endogenous circadian oscillation in the
SCN. The oscillation of the SCOP protein was also detected
in the retina (data not shown), another possible circadian
oscillator in mammals [19,20]. Considering these facts, it
seems likely that SCOP protein is a candidate for a part of
the clock machinery in the SCN, although its function re-
mains to be elucidated.
From the deduced amino acid sequence, it was revealed that
SCOP protein has characteristic domains. The PH domain is
Fig. 5. Immunoblot analysis for the expression of SCOP protein in the SCN. Protein extracts (10 Wg protein per lane) were prepared at di¡er-
ent CTs from the SCN and the part of the hypothalamus outside the SCN of 6 week old male rats, and analyzed for the expression of SCOP
protein by Western blotting with anti-SCOP antibody (KEC). A: Each case of Western blots done twice under DD condition is shown. The
lanes from left to right show the data sampled at CT 0, 3, 6, 9, 12, 15, 18 and 21, respectively. B: Coomassie brilliant blue staining of the pro-
teins resolved on the SDS-PAGE gel, indicating that the same amount of protein was applied to each lane. Numbers shown on the left side of
the gels indicate positions of molecular size marker proteins in kDa. C: Quanti¢cation of the relative levels of the immunoreactivities for
SCOP protein determined by a densitometer. The times of sampling are indicated on the abscissa. Data are expressed as means þ S.E.M.
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known to be included in some signaling molecules such as
phospholipid-dependent protein kinase, Akt [21,22]. The in-
teraction of the PH domain with phosphatidylinositol is
known to be crucial for intracellular signal transmission medi-
ated by PI3 kinase [23]. This raises the possibility that SCOP
is involved in the intracellular signaling pathway through in-
teraction with a membrane component. On the other hand,
SCOP has LZip and a Q-rich region which have functional
implications in the nucleus. From these structural features, it
is hypothesized that SCOP’s function is di¡erent in the mem-
brane compartment and in the nucleus, or is a mediator of a
signal from the membrane to the nucleus. In fact, the subcel-
lular fractionation of the rat brain demonstrated that SCOP
protein was recovered in either the membrane, cytoplasmic or
the nuclear fractions. Further analysis must be done to eluci-
date the function of SCOP.
Both LRRs and PP2C-like domains are known to be con-
served in adenylate cyclase of yeast. LRRs are also found in a
variety of proteins with diverse biological functions and are
proposed to mediate protein-protein interactions. Yeast ad-
enylate cyclase contains 26 LRRs [24] that are required for
binding to and activation by Ras during vegetative yeast
growth [25,26]. Recent ¢ndings suggest that SOC-2 [27] and
SUR-8 [28] having LRR domains homologous to yeast adeny-
late cyclase LRR bind to Ras and regulate Ras-mediated sig-
naling. Thus, it is possible that SCOP is involved in the Ras-
mediated signaling through the interaction between the SCOP
LRR and Ras. The PP2C-like domain of SCOP is similar to
not only the catalytic domains of PP2C of yeast and Para-
mecium, but also the PP2C-like domains of adenylate cyclases
of several species. However, there is no report describing the
phosphatase activity in the PP2C-like domain of adenylate
cyclase. Likewise, the phosphatase activity of SCOP has not
yet been detected in vitro in our laboratory (data not shown).
There may be a speci¢c activator or speci¢c substrates for
SCOP in vivo, although the possibility cannot be excluded
that the PP2C-like domain has other functions than that of
phosphatase. To clarify the function of these domains of
SCOP, interacting proteins to the domains in vivo should be
examined.
Here we described the identi¢cation of a novel protein,
SCOP, that oscillated in a circadian manner in the SCN.
Whether SCOP is indeed a part of the circadian clock, and
if so, how SCOP is involved in the circadian oscillators, and
what the actual function of the SCOP molecule is in the neu-
ral cells must be examined in the near future.
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